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Sir, 
Thank you for giving us the opportunity to respond to the letter by Rometsch et al about 
the PROFHER trial. 
We note that this AO Foundation-funded ‘critical appraisal’ of the PROFHER trial has 
been linked primarily with the report of the five-year follow-up[1] rather than with the 
main trial report published in JAMA[2] and the comprehensive National Institute for 
Health Research (NIHR) Health Technology Assessment (HTA) monograph[3]. Perusal 
by Rometsch et al of both of these reports will address many of their concerns; for 
example, about the expertise of the operating surgeons and on the availability of topic-
specific estimates of the minimal clinically important change (MCID) for the Oxford 
Shoulder Score (OSS). Further pertinent insights are available in our article on defining 
the fracture population.[4] 
We further refer Rometsch et al to our letter[5] detailing the unsound methods, analyses 
and conclusions of the meta-analysis conducted by Sabharwal et al.[6] Other unsound 
methodology is their suggestion for a per-protocol analysis. Such analysis is rarely, if 
ever, justified.[7] 
Finally, we suggest that Rometsch et al examine the systematic approach taken in the 
critical appraisal of the PROFHER trial in a recent ‘User’s guide’ to the medical literature 
relating to surgical trials.[8] 
We hope that by taking these steps, Rometsch et al will accept that the conclusion of the 
trial was appropriate and applicable to the majority of patients with displaced proximal 
humeral fractures involving the surgical neck. 
HH Handoll, Reader in Orthopaedics, Teesside University, 
Teesside, Middlesbrough, UK. 
SD Brealey,  
A Keding,  
A Rangan. 
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